Wuhan Wansheng Biotechnology
Finnrick has tested 222 samples from Wuhan Wansheng Biotechnology across 9 products.
Fraud: Based on community reports, we have identified wuhanwanshengbio.com as a fraudulent web site aggressively operating in the name of this vendor. It is most likely entirely unaffiliated with the original company, the fraud is putting the public at risk, so we are temporarily putting all tests under review.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| BPC-157 | 18 | 18 Sep 2025 | 6 May 2026 | |||||
| Cagrilintide | 14 | 21 Oct 2025 | 6 May 2026 | |||||
| CJC-1295 | 7 | 29 Oct 2025 | 6 Mar 2026 | |||||
| GHK-Cu | 21 | 4 Aug 2025 | 13 May 2026 | |||||
| Ipamorelin | 13 | 11 Aug 2025 | 28 Apr 2026 | |||||
| Retatrutide | 65 | 4 Aug 2025 | 25 May 2026 | |||||
| TB-500 | 8 | 4 Aug 2025 | 25 Mar 2026 | |||||
| Tesamorelin | 25 | 11 Aug 2025 | 28 Apr 2026 | |||||
| Tirzepatide | 50 | 31 Aug 2025 | 6 May 2026 | |||||
The Wuhan Wansheng Biotechnology samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Wuhan Wansheng Biotechnology tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 May 2026 | Retatrutide | View | 50mg | 50.5mg | +1.0% | 99.90% | (no batch ID) | No label / Black crimp / Clear cap | Lab G | Public | |
| 18 May 2026 | Retatrutide | View | 20mg | 21.5mg | +7.5% | 99.60% | Apr 2, 2026 | No label / Gold crimp / Clear cap | Lab G | Public | |
| 13 May 2026⚠️ | GHK-Cu | View | 50mg | 51.3mg | +2.6% | 99.70% | WWB-0425-EGB0525-02 | White Label / Silver Crimp / White Cap | Lab E | Public | |
| 8 May 2026⚠️ | Retatrutide | View | 30mg | 25.8mg | -14.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Clear Yellow Cap | Lab E | Public | |
| 6 May 2026⚠️ | Cagrilintide | View | 5mg | 4.3mg | -14.0% | 99.90% | (no batch ID) | White Label / Silver Crimp / Green Cap | Lab E | Public | |
| 6 May 2026⚠️ | Tirzepatide | View | 20mg | 18mg | -10.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 6 May 2026⚠️ | BPC-157 | View | 20mg | 19.98mg | -0.1% | 99.30% | (no batch ID) | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
About Wuhan Wansheng Biotechnology Test Results From Finnrick
Wuhan Wansheng Biotechnology is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 9 products and 222 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Wuhan Wansheng Biotechnology Testing Activity & Score Summary
In the past 30 days, Finnrick has published 9 new test results for Wuhan Wansheng Biotechnology, and 33 in the past three months. The overall dataset includes 222 tested samples with an average score of 6.8/10 across all products.
Across 222 identity-tested samples, 98% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 90% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Tirzepatide (50 tests, 98% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 2.8 to 10.0 (average 7.0/10), suggesting significant batch-to-batch differences.
- Retatrutide (65 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 4.1 to 10.0 (average 7.5/10), suggesting significant batch-to-batch differences.
- Tesamorelin (25 tests, 96% identity pass, median purity 98.9%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 5.3/10), suggesting significant batch-to-batch differences.